← Feed

PERRY MICHAEL S

SEC Form 4 insider
ARROWHEAD PHARMACEUTICALS, INC. ($ARWR)
1 thesis · first seen Aug 20, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$ARWRSEC Form 4bearish
PERRY MICHAEL S · ARROWHEAD PHARMACEUTICALS, INC. · 6h agono track record yet
Sold 11,600 @ $87.30 avg · $1,012,680 · 2026-08-18

Form 4: PERRY MICHAEL S sold ARWR

PERRY MICHAEL S (Director at ARROWHEAD PHARMACEUTICALS, INC.) reported an open-market sale of 11,600 shares of ARWR at an average $87.30, roughly $1,012,680, in a Form 4 filed 2026-08-20.

View filing on SEC.gov →

End of results.